Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
2
×
boston top stories
clinical trials
life sciences
national blog main
national top stories
new york blog main
new york top stories
san diego blog main
san diego top stories
san francisco blog main
2
×
san francisco top stories
allergan
blueprint medicines
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
cancer
clinical data
companion diagnostic
detroit blog main
detroit top stories
dna sequencing
drugs
entrectinib
express scripts
fda
foundation medicine
genfit
gilead sciences
indiana blog main
indiana top stories
intercept pharmaceuticals
josh bilenker
keytruda
larotrectinib
ldl-c
liver
liver disease
loxo oncology
What
approved
2
×
drug
2
×
medicine
new
2
×
cancer
data
deeper
disease
dna
fatty
fda
fingerprint
genetic
going
horizon
intercept
known
liver
marketed
matter
nash
nd
nonalcoholic
oks
second
steatohepatitis
targets
time
tissues
track
tumor's
world
Language
Current search:
new
×
drug
×
" boston blog main "
×
" san francisco blog main "
×
approved
×
@xconomy.com
5 years ago
With New Data, Intercept On Track for First-Ever Approved NASH Drug
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues